首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Antibody therapeutics

缩写:

ISSN:N/A

e-ISSN:2516-4236

IF/分区:4.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引215
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Peng Zhao,Ningyan Zhang,Zhiqiang An Peng Zhao
Diseases in the central nervous system (CNS) are often difficult to treat. Antibody- and protein-based therapeutics hold huge promises in CNS disease treatment. However, proteins are restricted from entering the CNS by the blood-brain barri...
Han Kee Ong,Ngan T B Nguyen,Jiawu Bi et al. Han Kee Ong et al.
Background: Two-armed FabscFv-Fc is a favoured bispecific antibody (BsAb) format due to its advantages of the conventional IgG structure. Production of FabscFv-Fc requires expression of three polypeptide chains, one light...
Barbara Frigerio,Matilde Montermini,Canevari Silvana et al. Barbara Frigerio et al.
In the 1980s, we developed and characterized numerous murine monoclonal antibodies (MAbs) directed against human tumor-associated antigens. This mini review is focused on the generation of derivatives of an anti-folate receptor α (FRα) MA...
Yong Zhu,Shawn Shouye Wang,Zhaohui Sunny Zhou et al. Yong Zhu et al.
To date, close to 100 canonical monoclonal antibody drugs have been approved by the FDA; furthermore, a number of antibody-derived therapeutics in nontraditional formats have reached late development stages and the market, and many more are...
Ehsan Espah Borujeni,Weixin Jin,Chun Shao et al. Ehsan Espah Borujeni et al.
Background: Bispecific antibodies (BsAb) belong to a novel antibody category with advantages over traditional mono-specific therapeutic antibodies. However, product variants are also commonly seen during the production of...
Ruth Bone,Brian J Fennell,Amy Tam et al. Ruth Bone et al.
Background: Interleukin (IL)25 has been implicated in tissue homeostasis at barrier surfaces and the initiation of type two inflammatory signaling in response to infection and cell injury across multiple organs. We sought...
Xiaochen Lyu,Qichao Zhao,Julia Hui et al. Xiaochen Lyu et al.
Antibody therapies have become an important class of therapeutics in recent years as they have exhibited outstanding efficacy and safety in the treatment of several major diseases including cancers, immune-related diseases, infectious disea...
Kristopher A Lofgren,Nicolette C Reker,Sreeja Sreekumar et al. Kristopher A Lofgren et al.
Amphiregulin is a transmembrane protein which, when cleaved by the TACE/ADAM17 protease, releases a soluble epidermal growth factor receptor ligand domain that promotes proliferation of normal and malignant cells. We previously described a ...
Bo Wang,Jun Lin,Matthew R Hoag et al. Bo Wang et al.
The classical `knob-into-holes' (KIH) strategy (knob(T366Y)/hole (Y407T)) has successfully enhanced the heterodimerization of a bispecific antibody (BsAb) resulting in heterodimer formation up to 92% of protein A (ProA)-purified protein poo...
Joshua R Laber,Thomas M Laue,Dana I Filoti Joshua R Laber
The diffusion interaction parameter (kD ) has been demonstrated to be a high-throughput technique for characterizing interactions between proteins in solution. kD reflects both attractive and repulsive interactions, including long-ranged el...